Andere Sprachen Morinaga Milk Industry Co., Ltd.

Aktien

857223

JP3926800008

2264

Verzögert Japan Exchange Andere Börsenplätze 08:00:00 01.05.2024			% 5 Tage	% 1. Jan.
3’105 ^JPY	+0.58%		+1.60%	+13.82%

2023	Das Probiotikum Bifidobacterium B-3 von Morinaga Milk Industry Co., Ltd. erhält in Südkorea die Genehmigung zur individuellen Registrierung	CI
2023	Morinaga Milk Industry Co., Ltd. revidiert Gewinnprognose für die ersten sechs Monate bis zum 30. September 2023 und für das Geschäftsjahr bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hundreds in northeast Japan get sick after drinking school lunch milk	26.04.
Morinaga Milk Industry Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	09.02.
Morinaga Milk Industry Relocates Headquarters to a Newer Building in Minato-ku, Tokyo	18.01.
Morinaga Milk Industry Co., Ltd. Announces Change of Address	18.01.
Morinaga Milk’s Probiotic Bifidobacterium breve B-3 Receives Approval of Individual Recognized Registration in South Korea	17.11.
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium B-3 Receives Approval of Individual Recognized Registration in South Korea	17.11.
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	01.11.
Morinaga Milk Industry Co., Ltd.'s Equity Buyback announced on May 15, 2023, has closed with 1,856,400 shares, representing 4.14% for ¥9,999.53 million.	31.10.23
Morinaga Milk Industry Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	26.10.23
Morinaga Milk Industry Co., Ltd. Revises Earnings Guidance for the First Six Months Ended September 30, 2023 and for the Fiscal Year Ending March 31, 2024	26.10.23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	02.10.23
Morinaga Milk recibe la aprobación de la ANVISA en Brasil, incluyendo la declaración de funcionalidad para la salud intestinal, para el probiótico bifidobacterium longum, subespecie longum BB536	08.09.23
Morinaga Milk's Probiotic Bifidobacterium longum subsp. longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07.09.23
Morinaga Milk Industry Co., Ltd.'s Probiotic Bifidobacterium Longum BB536 Receives ANVISA Approval with Gut Health Functional Claim in Brazil	07.09.23
Morinaga Milk Industry Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2024	09.08.23
Morinaga Milk Industry Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09.08.23
Morinaga Milk Industry Issues Restricted Stock Compensation	02.08.23
Tranche Update on Morinaga Milk Industry Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.	03.07.23
Morinaga Milk Industry Co., Ltd. completed the acquisition of 20% stake in Morinaga Le May Vietnam Joint Stock Company from Le Van May and Do Thanh Tuan.	31.05.23
Morinaga Milk Industry Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	15.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Morinaga Milk Industry Co., Ltd.

Aktien

857223

JP3926800008

2264

Andere Sprachen

Filter